Oxford Finance

  • Team
  • Life Sciences
  • Healthcare
    • Real Estate
    • Leveraged Lending
  • News
  • Contact Us

Author: Selma Basic

Pliant Therapeutics Enters into $100 million Loan Facility Agreement with Oxford Finance to Support Ongoing Development of PLN-74809

May 5, 2022

By Selma Basic

Up to $100 million of non-dilutive capital from Oxford Finance LLC Extends expected cash runway to mid-2024 SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. … Continued

Read More

Oxford Finance Healthcare Real Estate Q1 2022 Recap

April 25, 2022

By Selma Basic

Oxford’s Healthcare Real Estate Group closed over $280 million in transaction volume in the first quarter of 2022, providing credit facilities ranging from $5 million to over $110 million. Q1 … Continued

Read More

Oxford Finance Announces the Closing of a $75 Million Credit Facility With Fusion Pharmaceuticals

April 5, 2022

By Selma Basic

Funding will support Fusion’s growing pipeline of targeted alpha therapies for the treatment of cancer ALEXANDRIA, Va. & HAMILTON, Ont. –(BUSINESS WIRE)– Oxford Finance LLC (“Oxford”), a leading specialty finance … Continued

Read More

Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors

March 28, 2022

By Selma Basic

Company Secures up to $150 Million in Non-Dilutive Funding from Oxford Finance LLC, Providing Additional Financial Flexibility Expected Cash Runway Through 2025; Supports Continued Development and Potential Commercial Launches of VS-6766 and Defactinib BOSTON–(BUSINESS WIRE)–Mar. … Continued

Read More

Oxford Finance Leads $660 Million Upsize Financing for Specialty Dental Brands

March 24, 2022

By Selma Basic

ALEXANDRIA, Va. and NASHVILLE, Tenn., –(BUSINESS WIRE)–Oxford Finance LLC (“Oxford”), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a … Continued

Read More

Lexicon Enters Into Loan Facility With Oxford Finance for Up to $150 Million to Support Planned Commercialization of Sotagliflozin

March 17, 2022

By Selma Basic

The Woodlands, Texas, March 17, 2022 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it entered into a loan facility with Oxford Finance LLC that provides up to $150 million in … Continued

Read More

Posts navigation

Older posts

© 2022 Oxford Finance LLC

Privacy Policy Terms of Service
Loans made or arranged pursuant to a California Financing Law License.
  • Home
  • Team
  • Life Sciences
  • Healthcare
  • News
  • Contact Us